The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy
Abstract
Background— The anti-ischemic agent trimetazidine improves ejection fraction in heart failure that is hypothetically linked to inhibitory effects on cardiac free fatty acid (FFA) oxidation. However, FFA oxidation remains unmeasured in humans. We investigated the effects of trimetazidine on cardiac perfusion, efficiency of work, and FFA oxidation in idiopathic dilated cardiomyopathy. Methods and Results— Nineteen nondiabetic patients with idiopathic dilated cardiomyopathy on standard medication were randomized to single-blind trimetazidine (n=12) or placebo (n=7) for 3 months. Myocardial perfusion, FFA, and total oxidative metabolism were measured using positron emission tomography with [ 15 O]H 2 O, [ 11 C]acetate, and [ 11 C]palmitate. Cardiac function was assessed echocardiographically; insulin sensitivity was assessed by the homeostasis model assessment index. Trimetazidine increased ejection fraction from 30.9±8.5% to 34.8±12% ( P =0.027 versus placebo). Myocardial FFA uptake was unchanged, and β-oxidation rate constant decreased only 10%. Myocardial perfusion, oxidative metabolism, and work efficiency remained unchanged. Trimetazidine decreased insulin resistance (glucose: 5.9±0.7 versus 5.5±0.6 mmol/L, P =0.047; insulin: 10±6.9 versus 7.6±3.6 mU/L, P =0.031; homeostasis model assessment index: 2.75±2.28 versus 1.89±1.06, P =0.027). The degree of β-blockade and trimetazidine interacted positively on ejection fraction. Plasma high-density lipoprotein concentrations increased 11% ( P <0.001). Conclusions— In idiopathic dilated cardiomyopathy with heart failure, trimetazidine increased cardiac function and had both cardiac and extracardiac metabolic effects. Cardiac FFA oxidation modestly decreased and myocardial oxidative rate was unchanged, implying increased oxidation of glucose. Trimetazidine improved whole-body insulin sensitivity and glucose control in these insulin-resistant idiopathic dilated cardiomyopathy patients, thus hypothetically countering the myocardial damage of insulin resistance. Additionally, the trimetazidine-induced increase in ejection fraction was associated with greater β1-adrenoceptor occupancy, suggesting a synergistic mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Kantor, P. F., Lucien, A., Kozak, R., & Lopaschuk, G. D. (2000) · Circulation Research · doi:10.1161/01.res.86.5.580 · Cited by 813
Glycemic Control and Heart Failure Among Adult Patients With Diabetes
Iribarren, C., Karter, A. J., Go, A. S., Ferrara, A., Liu, J. Y., Sidney, S., & Selby, J. V. (2001) · Circulation · doi:10.1161/01.cir.103.22.2668 · Cited by 710
Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure
Swan, J. W., Anker, S. D., Walton, C., Godsland, I. F., Clark, A. L., Leyva, F., Stevenson, J. C., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00185-x · Cited by 533
Metabolic Mechanisms in Heart Failure
Ashrafian, H., Frenneaux, M. P., & Opie, L. H. (2007) · Circulation · doi:10.1161/circulationaha.107.702795 · Cited by 521
Self-citationNikolaidis, L. A., Elahi, D., Hentosz, T., Doverspike, A., Huerbin, R., Zourelias, L., Stolarski, C., Shen, Y.-T., & Shannon, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000139339.85840.dd · Cited by 514
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
Dávila-Román, V. G., Vedala, G., Herrero, P., de las Fuentes, L., Rogers, J. G., Kelly, D. P., & Gropler, R. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01967-8 · Cited by 513
Insulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 351
Protons in ischemia: Where do they come from; Where do they go to?
Dennis, S. (1991) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(91)91642-5 · Cited by 343
Eichhorn, E. J., Heesch, C. M., Barnett, J. H., Alvarez, L. G., Fass, S. M., Grayburn, P. A., Hatfield, B. A., Marcoux, L. G., & Malloy, C. R. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90114-7 · Cited by 306
Doehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I. F., von Haehling, S., Okonko, D. O., Leyva, F., Proudler, A. J., Coats, A. J. S., & Anker, S. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.093 · Cited by 294
Fragasso, G., Palloshi, A., Puccetti, P., Silipigni, C., Rossodivita, A., Pala, M., Calori, G., Alfieri, O., & Margonato, A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.060 · Cited by 270
Lopaschuk, G. D., Wambolt, R. B., & Barr, R. L. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10243-7 · Cited by 265
Wallhaus, T. R., Taylor, M., DeGrado, T. R., Russell, D. C., Stanko, P., Nickles, R. J., & Stone, C. K. (2001) · Circulation · doi:10.1161/01.cir.103.20.2441 · Cited by 253
Pilz, J., Meineke, I., & Gleiter, C. H. (2000) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00174-2 · Cited by 252
Fragasso, G., Perseghin, G., De Cobelli, F., Esposito, A., Palloshi, A., Lattuada, G., Scifo, P., Calori, G., Del Maschio, A., & Margonato, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi816 · Cited by 250
Tuunanen, H., Engblom, E., Naum, A., Någren, K., Hesse, B., Airaksinen, K. E. J., Nuutila, P., Iozzo, P., Ukkonen, H., Opie, L. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.645184 · Cited by 238
Self-citationFragasso, G., Piatti, M., Monti, L., Palloshi, A., Setola, E., Puccetti, P., Calori, G., Lopaschuk, G. D., & Margonato, A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00415-0 · Cited by 202
Sorokina, N., O’Donnell, J. M., McKinney, R. D., Pound, K. M., Woldegiorgis, G., LaNoue, K. F., Ballal, K., Taegtmeyer, H., Buttrick, P. M., & Lewandowski, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.668665 · Cited by 193
VITALE, C., WAJNGATEN, M., SPOSATO, B., GEBARA, O., ROSSINI, P., FINI, M., VOLTERRANI, M., & ROSANO, G. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.034 · Cited by 182
Glucose Metabolism in the Ischemic Heart
Lopaschuk, G. D., & Stanley, W. C. (1997) · Circulation · doi:10.1161/01.cir.95.2.313 · Cited by 174
Endocrine Control of Metabolism
Randle, P. J. (1963) · Annual Review of Physiology · doi:10.1146/annurev.ph.25.030163.001451 · Cited by 164
Pike, V. W., Eakins, M. N., Allan, R. M., et al. (1982) · The International Journal of Applied Radiation and Isotopes · doi:10.1016/0020-708x(82)90003-5 · Cited by 162
Iozzo, P., Chareonthaitawee, P., Dutka, D., Betteridge, D. J., Ferrannini, E., & Camici, P. G. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3020 · Cited by 160
Self-citationNikolaidis, L. A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.027 · Cited by 155
Quantitation of myocardial fatty acid metabolism using PET.
Bergmann, S. R., Weinheimer, C. J., Markham, J., & Herrero, P. (1996) · PubMed · Cited by 131
Belardinelli, R. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2653 · Cited by 128
Iida, H., Takahashi, A., Tamura, Y., Ono, Y., & Lammertsma, A. A. (1995) · PubMed · Cited by 119
Insulin resistance in idiopathic dilated cardiomyopathy
Witteles, R. M., Tang, W. H. W., Jamali, A. H., Chu, J. W., Reaven, G. M., & Fowler, M. B. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.037 · Cited by 117
Tuunanen, H., Engblom, E., Naum, A. S., Scheinin, M., Någren, K., Airaksinen, J. K. E., Nuutila, P., Iozzo, P., Ukkonen, H., & Knuuti, J. M. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.06.005 · Cited by 104
Self-citationPanchal, A. R., Stanley, W. C., Kerner, J., & Sabbah, H. N. (1998) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(98)90252-4 · Cited by 101
Monti, L. D., Setola, E., Fragasso, G., Camisasca, R., Lucotti, P., Galluccio, E., Origgi, A., Margonato, A., & Piatti, P. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00083.2005 · Cited by 73
Bengel, F. M., Permanetter, B., Ungerer, M., Nekolla, S. G., & Schwaiger, M. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050040 · Cited by 69
Emerging Therapies for the Management of Decompensated Heart Failure
deGoma, E. M., Vagelos, R. H., Fowler, M. B., & Ashley, E. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.039 · Cited by 55
Myocardial fatty acid oxidation in patients with impaired glucose tolerance
Knuuti, J. M., Takala, T., N�gren, K., Sipil�, H., Turpeinen, A., Uusitupa, M. I. J., & Nuutila, P. (2001) · Diabetologia · doi:10.1007/s001250051597 · Cited by 55
Self-citationOPIE, L., & BRICKNELL, O. L. (1979) · Cardiovascular Research · doi:10.1093/cvr/13.12.693 · Cited by 52
Self-citationTriacylglycerol metabolism in hypoxic, glucose-deprived rat cardiomyocytes
Myrmel, T. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)91099-q · Cited by 45
Beanlands, R. S., Armstrong, W. F., Hicks, R. J., Nicklas, J. M., Moore, C. K., Hutchins, G. D., Wolpers, H. G., & Schwaiger, M. (1994) · Journal of Nuclear Cardiology · doi:10.1007/bf02940007 · Cited by 44
Antman, E. M. (2003) · American Heart Journal · doi:10.1016/j.ahj.2003.09.001 · Cited by 38
Bøttcher, M., Refsgaard, J. C., Gøtzsche, O., Andreasen, F., & Nielsen, T. T. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02351-2 · Cited by 16
SAKUMA, N., Saeki, T., Yajima, K., Hibino, T., Yoshida, T., MIZUNO, H., Mukai, S., SAKATA, S., KUNIMATSU, M., & Kimura, G. (2005) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.51.75 · Cited by 3
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citation2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Self-citation2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Self-citation
Metadata
- Authors
- Tuunanen, H., Engblom, E., Naum, A., Någren, K., Scheinin, M., Hesse, B., Juhani Airaksinen, K. E., Nuutila, P., Iozzo, P., Ukkonen, H., Opie, L. H., & Knuuti, J.
- Venue
- Circulation
- Published
- 2008-09-16
- Volume
- 118
- Issue
- 12
- Pages
- 1250-1258
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2019999805
- Cited by
- 266
- References
- 43
- FWCI
- 14.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.